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ALGORITMA KOLONI LEBAH TIRUAN BERSAMA EVOLUSI BERBEZA
UNTUK CIRI PENYARINGAN DAN PILIHAN DATA JISIM
SPEKTROMETRI
ABSTRAK
Kemajuan dalam teknik spektrometri jisim untuk kajian proteomik telah mening-
katkan penemuan pengecaman-bio daripada corak kuantitatif proteomik. Pemprosesan
data yang banyak untuk molekul yang terlibat boleh meningkat kepada siri puncak sa-
ling berkait dan bertindih di dalam spektrum jisim. Spektrum ini juga mengalami data
berdimensi tinggi berbanding saiz sampel yang kecil. Beberapa kajian telah mem-
perkenalkan teknik statistik dan pembelajaran mesin seperti Analisa Komponen Asas
((PCA)), Analisa Komponen Tak Bersandar ((ICA)) dan Analisa Riak Pekali (wavelet-
coefficient) untuk mengekstrak data yang berpotensi. Namun, tiada satu pun daripa-
da kaedah yang dibincangkan mengambil kira dengan serius masalah kelemahan data
yang berdimensi tinggi benbanding saiz sample yang kecil. Kajian ini telah tertumpu
kepada dua peringkat dalam analisa spektometri jisim. Pertama, kaedah ciri penya-
ringan iaitu akan menyaring puncak-puncak yang memberi inferens tentang maksud
biologi bagi data tersebut. Anggaran pengecutan bagi kovarians telah di cadangk-
an untuk mengumpul m/z windows dan mengenalpasti pekali korelasi terbaik antara
puncak-puncak bagi data spektometri jisim untuk ciri penyaringan. Kedua, kaedah ciri
pemilihan yang mencari ciri-ciri terbaik berdasarkan keputusan yang paling tepat da-
ripada model klasifikasi yang dijanakan. Suatu teknik pengkomputeran yang mimik
xiv
kepada kemandirian dan proses semulajadi yang di kenali sebagai Koloni Lebah Tiru-
an (ABC) digabungkan dengan pengklasifikasi SVM telah di cadangkan sebagai ciri
pemilihan dan kemudiannya dihibridkan dengan teknik Evolusi Berbeza (DE) sebagai
algoritma deABC untuk mengembangkan lagi fungsi eksplorasi algoritma ABC yang
asli. Kaedah yang dicadangkan ini telah diuji dengan data berdimensi tinggi daripa-
da Spektroskopi jisim yang melibatkan set data kanser ovari, hati (HCC) dan Toksik
Berasaskan Dadah (TOX) untuk menilai kuasa diskriminasi, ketepatan, kepekaan dan
spesifikasi. Untuk kaedah penyaringan, keputusan ciri diskriminasi yang di hasilkan
oleh anggaran pengecutan telah di uji dengan laporan kajian terdahulu dan menunjukk-
an keputusan yang lebih baik. Manakala untuk kaedah pilihan, perbandingan telah di-
buat dengan algoritma Particle Swarm Optimisation (PSO), Ant Colony Optimisation
(ACO) dan laporan kajian terdahulu sebagai ciri pemilihan. Algorithma deABC yang
dicadangkan telah menunjukkan ketepatan bagi 98.44, 88.89 dan 93.75 peratus untuk
set data kanser ovari, TOX dan hati (HCC) dan secara purata mengatasi prestasi PSO,
ACO dan kajian yang sama yang telah dilaporkan.
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ARTIFICIAL BEE COLONY WITH DIFFERENTIAL EVOLUTION
ALGORITHM FOR FEATURE EXTRACTION AND SELECTION OF MASS
SPECTROMETRY DATA
ABSTRACT
The advancement in mass spectrometry technique for proteomic studies has pro-
liferated the discovery of biomarkers from quantitative proteomics pattern. High-
throughput data for a given molecule can give rise to a series of inter-related and
overlapping peaks in a mass spectrum. The spectrum suffers from high dimensionality
data relative to small sample size. Several studies have proposed statistical and ma-
chine learning techniques such as Principle Component Analysis (PCA), Independent
Component Analysis (ICA) and wavelet-coefficient in order to extract the potential fea-
tures. However, none of these methods take into account the huge number of features
relative to small sample size. This study focused on two stages of mass spectrometry
analysis. Firstly, feature extraction methods extract peaks as potential features to infer
biological meaning of the data. Shrinkage estimation of covariance was proposed to
assemble m/z windows and identify the correlation coefficient among peaks of mass
spectrometry data for feature extraction. Secondly, feature selection techniques search
parsimonious features through a learning model that exhibits the most accurate re-
sults. A computational technique that mimics survival and natural processing known
as Artificial Bee Colony (ABC) integrated with linear SVM classifier was proposed for
feature selection. Later, this was hybrid with Differential Evolution (DE) techniques
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(deABC) algorithm in order to expand the exploration of basic ABC. The proposed
method was tested with several real-world high resolution mass spectrometry datasets
which are ovarian cancer, liver (HCC) and Drug-induced toxicity (TOX) datasets to
evaluate the discrimination power, accuracy, sensitivity and specificity. For feature ex-
traction, the analysis was made with reported studies. The shrinkage estimation has
performed better discriminative analysis on the similar features. For feature selection,
the comparisons have been made with Particle Swarm Optimisation (PSO), Ant Colony
Optimisation (ACO) algorithms and reported studies. The proposed feature selection
deABC algorithm exhibited accuracy of 98.44, 88.89 and 93.75 percent on ovarian
cancer, TOX and liver (HCC) datasets respectively and in average outperformed the
PSO, ACO and similar reported study.
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CHAPTER 1
INTRODUCTION
Bioinformatics can be viewed as the marriage of information technology with molecu-
lar biology and have covered algorithms, sequence representation, Markov modeling,
neural network to predict protein secondary structure and other mathematical model-
ing method for analysis and storage of biological data. Discussions in bioinformatics
frequently centered on two important biological molecules; (1) proteins and (2) nu-
cleic acids (Ho, 2007). Proteins work accordingly to achieve a particular function in
the cell, and they participate in every function of the cell. Meanwhile, nucleic acids
are very large and complex organic molecules that include DNA and RNA to transmit
genetic code from parents to offspring.
In proteins, many of them are enzymes that catalyse biochemical reactions, cell
signaling, immune responses, cell adhesion and the metabolism. Hence, proteomics
reveal large-scale studies of protein’s structure, function, protein-protein interaction,
and amounts expressed in living cells. In contrast to genomic, the proteomics study
reflects more accurately on the dynamic state of cell, tissue or an organism (Amelina,
2011).
One of the major concerns in proteomics study is how their quantities, modifica-
tions and structures change in response to the need of the body or in disease. As an
example, the cancer cells that often secrete specific proteins or fragments of proteins
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into the bloodstream and other body fluids such as urine, serum and saliva. Patterns of
proteins called protein signature in these easily accessible body fluids could provide in-
formation about the risk, presence, and progression of disease (Jurisicova et al., 2008;
Latterich et al., 2008; Paulovich et al., 2008). This knowledge ultimately could im-
prove the diagnosis and prognosis cancer cases in the early stage or before symptoms
are presented and customized treatment to the individual patient (therapy monitoring).
1.1 Background
In recent years, protein markers has shown great opportunity in diagnosis and prog-
nosis of diseases. A study done by Farina (2014) has shown the rising trend in the
proteomics cancer biomarker for the past 10 years. Proteomics biomarkers are based
on the idea that the major workhorse of biological system, diseases and other malfunc-
tions may be reflected by the proteomic level. As depicted in Figure 1.1, disturbances
in proteome are caused by mutation, such as faulty post-translation modification, in-
terference in protein-protein interaction, deleterious effects on pathways and networks
and unnatural changes in protein expression.
Traditionally, identification and quantification of single protein biomarker is ap-
plied for biomarker discovery. However, due to complexity of biological pathway and
heterogeneity between individual, single protein biomarker predictive utility might be
limited (Catchpole, 2013). Alternatively, the panel of biomarkers are utilised to evalu-
ate the activity of perturbation of biological system (Torrente et al., 2012; Sajic et al.,
2015). The advancement in tandem mass spectrometry (MS/MS) through quantitative
methods allow rapid identification and comparative quantification of several hundreds
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Figure 1.1: Effects of disturbances in proteome (figure taken from Parviainen et al.
(2014))
of proteins simultaneously (Pan et al., 2008).
The tandem mass spectrometry analysis produce huge number of peaks in high-
dimensionality mode that are used to identify peptides. These peaks are generated
from mass-to-charge ratio (m/z point) across the generated spectrum of MS data. Since
the spectrum of high dimensionality data consist of huge number of m/z points as
potential features, computational processing method is crucial for proper analysis and
identification. Since a decade, machine learning technique has played important roles
to generate reliable method for the complex analysis of raw data(Libbrecht and Noble,
2015). Generally, machine learning technique will process the raw high-dimensional
data into tractable number of features using feature selection techniques. Most of the
time, feature selection significantly plays as a vital key to balance the usage of few
features as possible while maintaining high predictive and discriminative power (Yu
et al., 2015). The balance is crucial since the goal is to produce highly accurate but
small panels of biomarkers with potential clinical utility (Swan et al., 2013).
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1.2 Motivation
High-resolution mass spectrometry generates extremely high-dimensional data of mass
spectra (Sajic et al., 2015) consist of tens of thousands points of mass to charge ratio
(m/z) of the substance. Each point might depict particular feature of protein or peptide.
This huge number of features are relative to small number of samples. Some of the
studies proposed particular statistical analysis to extract the data (Gibb and Strimmer,
2015), meanwhile some of the studies focusing on machine learning techniques such as
dimensional reduction and wavelet analysis to extract and identified the parsimonious
features (He et al., 2013; Neehar and Acharyya, 2013). However, none of these studies
really address the dimensionality that focus to huge numbers of features relative to
small sample size. This issue has been highlighted recently as crucial for biological
data (Schäfer et al., 2005; Yao et al., 2008; Sanavia et al., 2012).
The high-resolution data produces much complex peaks due to two level of frag-
mentation compared to low-resolution data. Therefore, neighbourhood peaks in high-
dimensionality data may infer similar proteins or peptides (He et al., 2009, 2013). Sev-
eral studies have constructed features from high-resolution data as group of neighbour-
hood peaks known as peaks-bins or m/z windows. However, the proposed methods
were machine dependent (Ressom et al., 2007) and the implementation of empirical
statistical analysis are sensitive to huge numbers of features relative to small sample
size (He et al., 2013). Therefore, a robust method to construct neigbourhood peaks
across different platform of mass spectrometry instrument and without limit to partic-
ular dataset are desirable. The method should also take into account the weakness of
empirical statistical analysis in evaluating the correlation of neighourhood peaks as a
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feature. Proper evaluation of neighbourhood peaks may also improve the discrimina-
tive characteristic of the features, thus capable to distinguish them between healthy and
disease cases. Instead of that, according to Mostacci et al. (2010), the real ’biological’
peaks are expected to sustain across samples. This is best known as reproducible issue
in mass spectrometry data. Statistical analysis such as feature ranking concern only
the correlation of the data, but does not evaluate the reproducible peaks across differ-
ent samples. Therefore, the reproducible issue of peaks in mass spectrometry is also
being highlighted in extracting the potential features (Zhang et al., 2010).
In the next phase of feature selection analysis, a classifier would accurately dis-
tinguish cancer and normal cases from entire thousands of features in spectra, but the
classification model does not help in finding specific biomarkers. Therefore, small
set of peaks are used to computationally predict markers with high accuracy (Ressom
et al., 2007) and then are considered as panel of biomarkers. On the other hand, the
feature selection method for biomarkers discovery are still open for improvement in
terms of better accuracy for prediction (Swan et al., 2015). Furthermore, the challenge
of biomarkers discovery also relies on robustness of the method that should be able to
identify markers from different types of dataset. Hence, it is motivating to study on
feature selection that is reliable in finding small set of marker over different types of
cancer cases.
1.3 Research Questions and Objectives
The objectives of this study are identified by answering the following research ques-
tions:
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1. How to assemble reliable and discriminative peaks-bins/ m/z windows from a
list of detected peaks from high dimensional data but small sample sizes? The
assumption is that strong correlation among peaks would represent a similar
protein. (Objective 1)
2. How to consider stable reproducible peaks for feature extraction? (Objective 1)
3. Is it possible for bio-inspired optimisation to efficiently collaborate with standard
classifier in order to select subset of features and generate high predictive and
discriminative power? (Objective 2)
4. Are the proposed feature selection method with the integrated classifier, able to
perform on different types of disease for biomarker discovery? (Objective 3)
The research objectives are:
1. To develop a feature extraction method that consider neighbourhood peaks and
discriminative characteristics that are robust for huge number of features with
relatively small sample sizes.
2. To develop a hybrid feature selection algorithm, built-in with SVM classifier that
optimise searching of parsimonious features for biomarker discovery.
3. To evaluate the predictive and discriminative power performance of classification
model for biomarker discovery from several diseases datasets.
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1.4 Significance of This Study
The cancer rates keep rising over the past two decades and yet the cure factor is still low
which raises alarming concern among the medical practitioner. According to Ander-
son (2010) even though several protein biomarkers have been introduced, the general
amount of new clinical protein biomarkers have been low within the recent years. This
is due to cost and effort to transform initial discovery to validated clinical solution
(Amelina, 2011; Parviainen et al., 2014).
Searching proteins that indicate disease through mass spectrometry (MS) analysis
has accelerated the discovery phenomena for biomarker identification. Computational
methods proposed in comparing protein expression levels in normal cases with cancer
cases sample lead to identification of potential biomarkers that can predict the de-
gree of malignancy in tumors (Libbrecht and Noble, 2015). Therefore, computational
technique is more reliable in reproducibility of prediction model of biomarkers in two
ways; (1) same disease but different experiments and datasets; (2) different diseases.
The results of the analysis provides valuable information about the efficacy of specific
anti-cancer treatments or help to identify new molecular target for innovative thera-
peutic strategies (Parviainen et al., 2014). Further, those particular biomarkers can be
used to evaluate the result of the treatments and monitor the long term recurrence of
the disease on specific patient (Hathout, 2015).
1.5 Research Scope and Limitation
The research scope and limitation for this study are listed as follows:
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1. Scope of data are label-free mass spectrometry from both MALDI and SELDI
techniques and limited to high-resolution datasets.
2. Development of the feature selection studies are limit to wrapper approach.
3. Focusing on bio-inspired algorithms for feature selection.
1.6 Thesis Organisation
In general, the research is organised into 7 chapters.
Chapter 2 serves as introduction to fundamental aspects of mass spectrometry anal-
ysis that covers brief introduction to the instrument for proteomics analysis, data rep-
resentation from the instruments, common mass spectrometry pipelines for biomarkers
discovery and followed by a list of pre-processing methods applied.
Chapter 3 discusses the literature reviews on both feature extraction and feature
selection in the domain of mass spectrometry analysis for biomarkers discovery. The
literatures start with general concept of feature extraction and selection in optimisation.
Further, the discussion focuses to the methods that applied to biomarkers discovery in
mass spectrometry data.
Chapter 4 gives an insight of the methodology used in this research. The whole ac-
tivities involved in this study on each phases are described and visualised. The phases
start with formatting of raw data, pre-processing, feature extraction, feature selection
and classification approaches. In addition, proposed methods on both feature extrac-
tion and selection are also highlighted in terms of the way data of mass spectrometry
is mapped to the method.
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Chapter 5 provides the extension of development of the proposed methods which
are mainly about constructing m/z windows using shrinkage estimation as potential
features and reproducible technique for feature extraction. While on feature selection,
details mechanism such as adaptation and modification of the ACB algorithm as feature
selection and further hybrid with Differential Evolution Algorithm are elaborated.
Chapter 6 covers the analysis and comparison of the analysis based on classification
predictive results and discriminative analysis. The analysis mainly based on accuracy,
sensitivity and specificity performance outputted from classification process, the ROC
representation and discriminative analysis on three different datasets.
Chapter 7 concludes the main finding of this research and proposed for future
works.
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CHAPTER 2
MASS SPECTROMETRY-BASED BIOMARKER DISCOVERY
STEPS
Mass spectrometry analysis is a complex process and contains complex mixture of pro-
teins data, therefore fundamental concept highlighted in this chapter intends to provide
clear picture of the basis in mass spectrometry data. Hence, the chapter begins with
an overview of MS, introduction to the instrument and the concept of tandem mass
spectrometry (MS/MS) as high resolution MS data. Next, the data representation for
the raw data is elaborated and followed by discussion on MS’s pipeline for biomarker
discovery. Lastly, several sub-task applied for the pre-treatment or pre-processing anal-
ysis are presented.
2.1 Mass Spectrometry Overview
Mass spectrometry is a powerful analytical technique used for the analysis of large
molecules. It is used to identify and quantify unknown compounds, determine molec-
ular masses of large biological samples, elucidate their structural and quantitative in-
formation, and investigate intermolecular re-actions. These properties hold high signif-
icance for an analytical chemist or a life scientist in order to understand the behaviour
of bio molecules that control biological systems and in turn, control our body. Mass
spectrometry provides valuable information to a wide range of professionals such as
chemist, biologist, astronomers and physician. For example, it is used to detect and
identify the use of steroids in athletes, monitor the breath of patients by anesthesiolo-
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Figure 2.1: Systematic identification and characterization of protein pattern from body
fluid for diagnosis and prognosis markers (figure taken from Seibert et al. (2004)).
gists during surgery, determine the composition of molecular species found in space,
and determine how drugs are used by the body (Aebersold and Mann, 2003). In addi-
tion, the MS technology offers a helping hand in the systematic identification and char-
acterization of protein for diagnostic and prognostic markers in tissue, blood serum and
other body fluids as depicted in Figure 2.1.
There are wide ranges of mass spectrometry instruments used for identification
and analysis in biotechnology itself. For example, Gas Chromatography with Mass
Spectrometry (GC/MS) used by chemists to identify structural features of compound;
Matrix-assisted laser desorption/ionization (MALDI) and Surface-Enhanced Laser Des-
orption Ionization (SELDI) used by pharmacists to identify proteomics patterns of pro-
teins and peptides for various applications include biomarker analysis (Seibert et al.,
2004). Both MALDI and SELDI techniques have created a beautiful insight towards
high-throughput proteomics analysis to the researchers across multi-disciplines. It
works on the principle that different molecules have different masses. Thus, once a
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substance is injected to the instrument, the constituent can be separated according to
their masses.
2.2 Principle in Mass Spectrometry (MS)
Mass spectrometry (MS) is producing ions of the analytical compounds and separating
ions according to their mass-to-charge-ratio (m/z). An important enhancement and
capabilities of mass spectrometry is currently being used in tandem with chromato-
graphic separation techniques. The two types of chromatography techniques adopted
are; (1) Gas chromatography that separates compound chromatographically using gas
in mobile phase; (2) Liquid chromatography that uses liquid in mobile phase which
usually contains a mixture of water and organic solvents. Mass spectrometer is split
into two main classes, the first class performs single mass spectrometry and the sec-
ond one performs tandem mass spectrometry (MS/MS). This study is only focused on
tandem mass spectrometry and will be explained in the next subsection. The measure-
ment of mass spectrometer instruments consist of three major components; ionization
source, the mass analyzer and the detector.
1. Ionization Source
As mentioned above the compound under analysis has to be ionized before the
mass can be measured and the ionization process is done in ionization source.
When dealing with peptides and protein, ionization is commonly achieved by
the addition of protons and the molecules. This addition also increases the mass
of the molecule by the nominal mass of 1 Da per charge (per proton). Sources
which cause only limited fragmentation are called soft ionization sources, as op-
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posed to hard ionization sources, in which components typically fragment upon
ionization. Soft ionization sources are used for peptides and proteins, and if
fragmentation is desired afterward (as in MS/MS) other post-source method are
used to achieve fragmentation. The most common uses of soft ionization in
proteomics are Electrospray Ionization (ESI) and Matrix-Assisted Laser Des-
orption Ionization (MALDI). Anyhow, focusing to biomarker analysis MALDI
and SELDI are most applicable ionization method (Ahmed, 2008).
2. Mass Analyzer
Mass analyzer separates ionized peptides according to mass-to-charge ratio (m/z).
This is achieved by the generation of electric or magnetic fields that separate
the ions based on trajectories, velocity or direction. Thus, mass analyzer is the
central of technology with the key parameters such as sensitivity, resolution,
mass accuracy and the ability to generate valuable information of mass spec-
tra from peptide fragmentation (MS/MS spectra) Aebersold and Mann (2003) .
At present, there are four basic types of mass analyser which have been used
in proteomics research; ion trap, time-of-flight (TOF), quadrupole and Fourier
Transform ion cyclotron (FT-MS) analyser. They are different in design and per-
formance, each with its own strength and weakness. Figure 2.2 shows how these
four types of mass analyzer incorporate in mass spectrometer.
3. Detector
Detector registers the relatives’number of ions at each m/z values and plots the
spectrum as abundance intensities in Y-axis versus mass-to-charge (m/z) ratio
of its ions in X-axis.
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Figure 2.2: Main component of a mass spectrometer (Figure taken from Cañas et al.
(2006)). Sample introduction device, ionization source for ion generation, mass an-
alyzer for ion separation, and ion detector to transform analogue signals into digital
signals and record a mass spectrum. Common ionization sources for proteomic re-
search are ESI and MALDI. Widespread mass analyzer are ion traps (a) Linear, (b)
Three-dimensional; (c) Triple quadroples; (d) Fourier transform cyclotron; and (e)
Time-of-flight (TOF). Usually ion trap and quadrupole analyzer are coupled to ESI ion
sources, whereas TOF analyzers are usually combined with MALDI ion source.
14
2.3 Tandem Mass Spectrometry (MS/MS)
Tandem mass spectrometry (MS/MS) is mainly used to produce structural information
about a compound by fragmenting specific sample ions inside the mass spectrometer
and identifying the resulting fragment ions (Parker and Borchers, 2014). Figure 2.3
shows the process of two level fragmentation from parent ion to produce daughter ion.
For example, the parent ion is any specific protein existing in the sample, whereby
daughter ion could be any peptides information that construct the protein. This in-
formation can then be pieced together to generate structural information regarding the
intact molecule. Tandem mass spectrometry also enables specific compounds to be
detected in complex mixtures on account of their specific and characteristic fragmen-
tation patterns.
The advancement in tandem mass spectrometry (MS/MS) which produces high-
resolution spectra embarks the in depth study of biomarkers through proteome profil-
ing (Sajic et al., 2015). Through tandem mass spectrometry, high number of peaks
are generated from a single spectrum of sample that represent peptides. Furthermore,
they are much better reproducibility between and within machine runs (Conrads et al.,
2003), thereby produce predicted model with higher sensitivity and accuracy. More-
over, the spectral resolution from low-level resolution or single fragmentation which
produced only parents ions, have no ability to produce specific ions that are close in
mass/charge, which can cause multiple specific discreet ions to coalesce into a single
peak (Petricoin and Liotta, 2004). High-resolution mass spectrometry analysis remains
to be seen as potential method for future clinical diagnostic platform.
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Figure 2.3: Process of fragmenting parent ions into daughter ions (MS/MS analysis).
Figure taken from Larsen et al. (2006)
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Figure 2.4: Text file from a sample of raw data in mass spectrometry
2.4 Data Representation
The raw data for each sample of mass spectrometry either disease or normal case is
commonly presented as CSV format or text files. The raw data is shown in Figure 2.4,
where the first column represents mass to charge ratio (m/z) values of the spectrum
and the second column represents relative signal intensity ion. The m/z is referred to
distribution of ions by mass in unit of dalton (Da).
Both disease and normal samples from the raw data are then compiled into man-
ageable form that combine all samples into a table of dataset which is easier to be
analysed as represented in Table 2.1. Each sample is viewed as a spectrum composed
of m/z on X-axis and intensity of particular m/z on Y-axis as portrayed in Figure 2.5.
Number of samples in different datasets might vary depending on how the data’s
are collected. For example, Figure 2.5 is depicted two spectrums from 216 samples
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Table 2.1: Data representation
m/z ratio
Cancer
sample1
Cancer
sample2 . . .
Cancer
samplek
Control
samplek+1 .....
Control
sample n
2000 0.1179 0.1735 0.3620 0.1727 0.0561
2000.384 0.1735 0.1619 0.2581 0.1238 0.0439
2000.786 0.2317 0.1883 0.1998 0.1078 0.0445
.
.
.
.
.
.
.
.
.
.
.
.
.
.
8787.623 0.0667 0.0425 0.0083 0.0241 0.0317
8788.428 0.0390 0.0345 0.0242 0.0275 0.0316
.
.
.
.
.
.
.
.
.
.
.
.
.
.
11899.063 0.0256 0.0131 0.0562 0.0357 0.0369
Figure 2.5: Sample of cancer and control spectrum from ovarian dataset
of Ovarian dataset that compose of 121 cancer cases and 95 control cases. From this
figure, potential features for predicting biomarkers rely on each mass-to-charge ratio
across 15,000 points on X-axis. Thus, tens of thousands potential features exhibit
biological meaning from only 216 samples existing in dataset.
2.5 Mass Spectrometry Pipeline in Biomarker Discovery
Mass spectrometry analysis is varied in techniques, Figure 2.6 depicts the pipeline in-
volved in the MS analysis for biomarker discovery which consider peaks as feature
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Figure 2.6: Mass Spectrometry pipeline
extraction method. In general, the whole process of biomarker discovery in mass spec-
trometry is classified into two levels which are; (1) low-level analysis which concerns
with cleaning the raw data and finding potential features; and (2) high-level analysis
which concerns on searching of parsimonious features and optimisation methods for
biomarker discovery (Ressom et al., 2005; Armananzas et al., 2011).
2.6 Pre-processing Analysis
The raw data acquired from mass spectrometry equipment is not only affected by noise
from the chemical source but also by variations and degradations encountered in prepa-
ration of the samples. This has been proved by several previous studies (Arneberg
et al., 2007; Cruz-Marcelo et al., 2008; Wang et al., 2010) that proposes and com-
pare several pre-treatment methods in order to standardize and maximize the quality of
the raw data. However, considerable improvements in the reliability and accuracy of
subsequent processes have been witnessed as a consequence of identifying and quan-
tifying all the potential features present in the sample. This section discusses several
pre-processing steps that can be performed in any order since there is no established
or gold standard methods (Cruz-Marcelo et al., 2008). Some of the important pre-
processing steps are as follows:
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Figure 2.7: Standard baseline removal in ovarian cancer dataset: Before baseline re-
moval
2.6.1 Baseline Removal
Baseline, or also known as background correction generally involves estimating and
subtracting the baseline from the signal (Yang et al., 2009). Mass spectrometry raw
data varies in their baseline across m/z values due to chemical contamination even for
the same datasets. This chemical noise mainly occurs in matrix or is caused by detector
overload during the experiment. The aim of baseline correction is to retain peak shape
and flattens non-peaks. Several methods have been proposed to subtract the baseline
across m/z axis. One of the common ways is to firstly adjust the variable baseline of
a raw mass spectrum by estimating the baseline with multiple shifted windows of a
specific width (Zhao and Davis, 2009). Secondly, a spline approximation algorithm
is employed to regress the varying baseline to the window points. Alternative to this
approach, a non-linear method such as top-hat morphological operator could be em-
ployed. A detailed discussion regarding baseline estimation and correction has been
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Figure 2.8: Standard baseline removal in ovarian cancer dataset: After baseline re-
moval
discussed in Shin et al. (2008). Meanwhile, Figure 2.7 and 2.8 shows the result of
before and after baseline removal for an ovarian cancer sample.
2.6.2 Noise Removing
Noise filtering process is aimed to clean the raw spectra from noise produced by elec-
tronic (white noise) and chemical sources by eliminating peaks which fall below a
pre-defined threshold. This process has been applied by various wavelet methods that
attempt to not only clean the noise but also smoothing the observed signals. Frequently,
the process of denoising and smoothing combine wavelet techniques with several types
of filtering methods such as Savitzky-golay filter, Gaussian filter and Moving-average
filter. More information about these methods are described by (Yang et al., 2009).
Figure 2.9 shows the result of removing noise from a spectrum.
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Figure 2.9: Noise removing and smoothing
2.6.3 Normalisation
Normalisation technique is applied to ensure that the sample falls on a specified range.
Specific to mass spectrometry data, since the intensity of peaks in inter-spectrum are
highly variable, normalisation is applied to increase the reliability of the data by using
them in uniform way. One of the widely used methods is by dividing each spectrum
by its Total Ion Current (TIC) and then rescaling the spectrum into relative intensity
values below 100 m/z. This method and other comparison studies have been explained
by Meuleman et al. (2008). Figure 2.10 depicts the normalisation result on a spectrum.
2.6.4 Alignment of Spectra
Due to large and high-throughput data from various spectra to be processed, alignment
of spectra has been done to ensure that the similar peaks for every spectrum are cor-
rectly matched and reflected to the same protein intensities. It can overcome errors that
could happen during the process of identifying peptide’s signal with molecular weight.
For example, biomarker discovery is to identify the location of peaks where peak inten-
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Figure 2.10: Normalise spectrum
sities (or absence /presence of peaks) have strong contrast between control and disease
individuals. Hereby, alignment of peaks are important before the comparison of same
peaks in different dataset is done.
Jeffries (2004) has proposed two algorithms to improve alignment among samples;
the first algorithm works with SELDI data produced by Chipergen instrument; and
the second is used for general format. The first algorithm is based on Chiphergen’s
conversion of time-of flight data to mass values via a quadratic equation. The second
algorithm was created by assuming that the data was represented in a two column for-
mat; X-axis for m/z values and Y-axis for intensities values. The concept of alignment
is based on fitting cubic splines to the data rather than quadratic equation. A detailed
discussion on alignment process has been done by Wong et al. (2005).
2.7 Chapter Summary
This chapter identify the fundamental of mass spectrometry data from the basic in-
struments until pre-processing approaches. The study has analysed the pre-processing
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methods and highlighted the mass spectrometry pipeline for biomarker discovery per-
taining to peaks extraction approach. The pipeline determines the importance of each
phase that may impact the quality of biomarkers discovery analysis. Hence careful
consideration for feature extraction and feature selection phases are the main concern
of this study and the proper analysis are performed in the next chapter.
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